Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Teriparatid, ATC H05AA02 für die Zeit 01.02.2024 - 31.01.2026
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- 101 Carefarm GmbH, 2care4 ApS, Aaragon Pharma s.r.o, Abacus Medicine A/S, Accord Healthcare GmbH, Allomedic GmbH, Aristo Pharma GmbH, axicorp Pharma B.V., BG ALIUD / STADAPHARM GbR, CC Pharma GmbH, EurimPharm Arzneimittel GmbH, Gedeon Richter Pharma GmbH, Heumann Pharma GmbH & Co. Generica KG, kohlpharma GmbH, Medicopharm AG, Orginalis BV, Orifarm GmbH, Sun Pharmaceuticals Germany GmbH, Theramex Ireland Ltd.
- Contract value
- no value published
- Bids received
- 18
- Published
- 29 Jan 2026
- Awarded
- 1 Feb 2024
- Contract start
- 1 Feb 2024
- Contract end
- 13 Feb 2025estimated
- Region
- Hamburg